Ernesto Araguas-Trallero

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Assessing the real-world impact of interstitial lung disease in patients with rheumatoid arthritis on healthcare resources and treatment patterns through natural language processing.

Assessing the real-world impact of interstitial lung disease in patients with rheumatoid arthritis on healthcare resources and treatment patterns through natural language processing.

Journal: EULAR rheumatology open

Published: August 01, 2026

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.

Journal: Seminars in arthritis and rheumatism

Published: March 07, 2026

Immunosuppression with ruxolitinib and abatacept in immune checkpoint inhibitor-associated myocarditis: a temporal cohort comparison.

Immunosuppression with ruxolitinib and abatacept in immune checkpoint inhibitor-associated myocarditis: a temporal cohort comparison.

Journal: Revista espanola de cardiologia (English ed.)

Published: March 04, 2026

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Journal: Journal of autoimmunity

Published: February 12, 2026

Myocardial involvement in inflammatory myopathies: from subclinical disease to life-threatening myocarditis.

Myocardial involvement in inflammatory myopathies: from subclinical disease to life-threatening myocarditis.

Journal: Expert review of clinical immunology

Published: February 03, 2026

Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive review.

Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive review.

Journal: Critical reviews in oncology/hematology

Published: September 26, 2025

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.

Journal: Annals of the rheumatic diseases

Published: July 13, 2025

Ultrasound-detected inflammation and structural changes in the joints, tendons and entheses of patients with cancer who developed arthritis or arthralgia after exposure to immune checkpoint inhibitors.

Ultrasound-detected inflammation and structural changes in the joints, tendons and entheses of patients with cancer who developed arthritis or arthralgia after exposure to immune checkpoint inhibitors.

Journal: RMD open

Published: May 07, 2025

Treatment and Monitoring of Eosinophilic Fasciitis.

Treatment and Monitoring of Eosinophilic Fasciitis.

Journal: Current treatment options in rheumatology

Published: March 21, 2025

Treatment Algorithms for Inflammatory Myopathies in Adults: from Guidelines to Clinical Practice.

Treatment Algorithms for Inflammatory Myopathies in Adults: from Guidelines to Clinical Practice.

Journal: Current treatment options in rheumatology

Published: January 01, 2025

Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events.

Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: December 13, 2024

Idiopathic inflammatory myopathy.

Idiopathic inflammatory myopathy.

Journal: Medicina clinica

Published: September 16, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026